Long-term albumin infusion in decompensated cirrhosis: A review of current literature

Abstract

Decompensated cirrhosis is characterized by chronic inflammation and severe portal hypertension leading to systemic circulatory dysfunction. Albumin infusion has been widely used in decompensated cirrhosis in patients with spontaneous bacterial peritonitis, large-volume paracentesis and hepatorenal syndrome. Emerging data suggest long-term albumin infusion has both oncotic and non-oncotic properties which may improve the clinical outcomes in decompensated cirrhosis patients. We review the current literature on both the established and potential role of albumin, and specifically address the controversies of long-term albumin infusion in decompensated cirrhosis patients.

Keywords: Acute-on-chronic liver failure; Albumin; Cirrhosis; Hepatic encephalopathy; Hepatorenal syndrome; Large-volume paracentesis; Spontaneous bacterial peritonitis.